ASTRAZENECA UK LIMITED
Company Information
- Company Number
- 03674842
- Registered Address
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA
- Status
- Active
- Employee Count
- 9,105
- Turnover
- £11,933,000,000
- EBITDA
- £1,478,000,000
Additional Details
- Website
- https://astrazeneca.com.br/
- Company Type
- Private limited Company
- Incorporated On
- 26 November 1998
- Nature of Business
- 70100 - Activities of head offices
- Industries
- Life Sciences And Medical Technology
- Region
- East of England
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 31 Jul 2025 | 47 | 27% | 71% | 2% | 1% |
| 01 Jul 2024 - 31 Dec 2024 | 14 Feb 2025 | 45 | 34% | 63% | 3% | 2% |
| 01 Jan 2024 - 30 Jun 2024 | 12 Jul 2024 | 49 | 29% | 68% | 3% | 2% |
| 01 Jul 2023 - 31 Dec 2023 | 23 Jan 2024 | 48 | 28% | 69% | 3% | 2% |
| 01 Jan 2023 - 30 Jun 2023 | 27 Jul 2023 | 57 | 31% | 66% | 3% | 4% |
| 01 Jan 2022 - 30 Jun 2022 | 28 Jul 2022 | 53 | 25% | 70% | 5% | 4% |
| 01 Jul 2021 - 31 Dec 2021 | 29 Jan 2022 | 51 | 41% | 54% | 5% | 4% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 51 | 15% | 80% | 5% | 3% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 48 | 36% | 60% | 4% | 0% |
| 01 Jan 2020 - 30 Jun 2020 | 29 Jul 2020 | 46 | 40% | 57% | 3% | 0% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 54 | 14% | 71% | 15% | 1% |
| 01 Jan 2018 - 30 Jun 2018 | 23 Jul 2018 | 52 | 17% | 71% | 12% | 1% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard terms range from immediate payment to 120 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
120
Dispute Resolution Process
Invoices are matched on receipt and disputed invoices notified to the supplier. Disputes are managed directly with the supplier and resolved items are reprocessed. Disputes are resolved within the existing payment terms.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
ASTRAZENECA UK LIMITED is a leading biopharmaceutical company based in the United Kingdom. The company is committed to improving the health and well-being of people around the world through innovative medicines and treatments.
The company's sustainability program focuses on reducing its environmental impact and promoting sustainability throughout its operations. This includes reducing greenhouse gas emissions, using renewable energy sources, and promoting sustainable sourcing and waste management practices.
ASTRAZENECA UK LIMITED offers a wide range of products and services, including prescription medicines, over-the-counter medicines, and vaccines. These products are used to treat a variety of conditions such as cancer, cardiovascular diseases, respiratory illnesses, and more.
Some key people at ASTRAZENECA UK LIMITED include the Chief Executive Officer, Pascal Soriot, and the Chairman, Leif Johansson. The company has over 8,000 employees in the UK and is a major contributor to the country's economy.
Contact information for ASTRAZENECA UK LIMITED can be found on their website, including their registered office address in Cambridge. The company's website also provides information on their products, research and development, and corporate responsibility efforts.
In summary, ASTRAZENECA UK LIMITED is a leading biopharmaceutical company with a strong commitment to sustainability and improving global health. With a diverse range of products and a dedicated team of professionals, the company is making a positive impact in the pharmaceutical industry.
